Levolin 50mcg Inhaler contains Levosalbutamol, a selective β2-adrenergic receptor agonist, indicated for the relief and prevention of bronchospasm in conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other reversible obstructive airway diseases. Each actuation delivers 50 micrograms of Levosalbutamol, which acts by relaxing the smooth muscles of the bronchial airways, leading to bronchodilation and improved airflow. Levolin Inhaler provides rapid onset of action, typically within minutes, making it effective for acute symptom relief. It is administered via inhalation, ensuring targeted delivery to the lungs and minimizing systemic side effects. The recommended dosage varies based on the severity of the condition and patient response, with careful titration advised to achieve optimal control while avoiding overuse. Common adverse effects include tremors, headache, palpitations, and nervousness, which are generally mild and transient. Caution is advised in patients with cardiovascular disorders, hyperthyroidism, or diabetes mellitus. Levolin 50mcg Inhaler should be used under medical supervision, and patients should be instructed on proper inhaler technique to maximize therapeutic efficacy. Regular monitoring and follow-up are essential to assess treatment response and adjust dosing accordingly.